EUVIMEDEUVIMED entdecken
Crossref

Design and synthesis of novel quinazolin‐4(1 H )‐one derivatives as potent and selective inhibitors targeting AKR1B1

Zhongfei Han, Jiahui Li, Zilu Xu, Yu Su, Yihan Wang, Lili Zhuo, Jiaming Du, Changjin Zhu, Xin Hao

Archiv der Pharmazie · 2023

DOI: 10.1002/ardp.202200577 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, 2023. Verfasst von Zhongfei Han und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chemistry and Chemical Engineering, Yancheng Institute of Technology, Yancheng, China. Hauptthemen laut MEDLINE: Aldehyde Reductase, Acetic Acid. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Natural Science Foundation of colleges and universities of Jiangsu Province, School-level research projects of Yancheng Institute of Technology, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inhibition of aldose reductase (AKR1B1) is a promising option for the treatment of diabetic complications. However, most of the developed small molecule inhibitors lack selectivity or suffer from low bioactivity. To address this limitation, a novel series of quinazolin‐4(1 H )‐one derivatives as potent and selective inhibitors of AKR1B1 were designed and synthesized. Aldose reductase inhibitory activities of the novel compounds were characterized by IC 50 values ranging from 0.015 to 31.497 μM. Markedly enhanced selectivity of these derivatives was also recorded, which was further supported by docking studies. Of these inhibitors, compound 5g exhibited the highest inhibition activity with selectivity indices reaching 1190.8. The structure–activity relationship highlighted the importance of N1‐acetic acid and N3‐benzyl groups with electron‐withdrawing substituents on the quinazolin‐4(1 H )‐one scaffold for the construction of efficient and selective AKR1B1 inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aldehyde ReductaseAcetic AcidStructure-Activity RelationshipEnzyme InhibitorsMolecular Docking Simulation

Stichwörter der Autor:innen

AKR1B1 inhibitordiabetic complicationsquinazolin-4(1H)-one

Substanzen

Aldehyde ReductaseAcetic AcidEnzyme Inhibitors

Autor:innen und Institutionen

  • Faculty of Chemistry and Chemical Engineering, Yancheng Institute of Technology, Yancheng, China.
  • Department of Applied Chemistry, Beijing Institute of Technology, Beijing, China.

Förderung

  • Natural Science Foundation of colleges and universities of Jiangsu Province
  • School-level research projects of Yancheng Institute of Technology
  • National Natural Science Foundation of China

Zitieren

APA

Han, Z., Li, J., Xu, Z., Su, Y., Wang, Y., Zhuo, L., Du, J., Zhu, C., & Hao, X. (2023). Design and synthesis of novel quinazolin‐4(1 H )‐one derivatives as potent and selective inhibitors targeting AKR1B1. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202200577

Vancouver

Han Z, Li J, Xu Z, Su Y, Wang Y, Zhuo L, et al. Design and synthesis of novel quinazolin‐4(1 H )‐one derivatives as potent and selective inhibitors targeting AKR1B1. Archiv der Pharmazie. 2023. doi:10.1002/ardp.202200577

BibTeX
@article{Han2023,
  author = {Han, Zhongfei and Li, Jiahui and Xu, Zilu and Su, Yu and Wang, Yihan and Zhuo, Lili and Du, Jiaming and Zhu, Changjin and Hao, Xin},
  title = {Design and synthesis of novel quinazolin‐4(1 H )‐one derivatives as potent and selective inhibitors targeting AKR1B1},
  journal = {Archiv der Pharmazie},
  year = {2023},
  doi = {10.1002/ardp.202200577}
}
Kostenlos starten →